Professionals discuss nuclear medicine
January 19, 2014 - 4:28:31 am
DOHA: Healthcare professionals from across Qatar on Friday gathered to discuss advances in Positron Emission Tomography (PET) and nuclear dedicine at the second Qatar PET and Molecular Nuclear Medicine Symposium (QPET-II), hosted by Hamad Medical Corporation (HMC) at Hajar Auditorium.
The event featured presentations and open discussions on PET-CT (a combination of PET and computed tomography) application in oncology, breast carcinoma and gynaecological malignancies, head and neck cancer, lung cancer, liver tumours, lymphoma and neuroendocrine tumours.
Participant also be discussed the evolution, clinical potential and future expectations of PET MRI (magnetic resonance imaging) hybrid imaging. Workshops will be conducted on the principles of nuclear medicine, and also on radiation protection for staff and family members.
“Hosting the event is part of our strategy to spread knowledge on cutting edge diagnostic and treatment monitoring technologies that will aid healthcare professionals in providing optimal patient care,” said QPET-II Chairperson Dr Nawal Al Tamimi, Consultant-Nuclear Medicine at the Radiology Department of HMC.
The symposium provided an opportunity for sharing experiences and knowledge, and will allow participants to learn from internationally recognized experts in the field. Speakers included Professor Adil Al Nahhas, Chief of Service of Nuclear Medicine at Imperial College Healthcare NHS Trust, UK; Dr Sze Ting Lee, Nuclear Medicine Physician at Austin Health in Australia; Dr. Salvatore Berlangieri, Head of the Clinical PET Program at Austin Health; and Dr. Ahmad Ibrahim Almuhaideb, Consultant Molecular Imaging Radiologist at King Faisal Specialist Hospital and Research Center and Professor Dr Ahmed Khairy, Senior Consultant at HMC’s Radiology Department.
Positron emission tomography (PET), also known as PET imaging or a PET scan, is a non-invasive, painless molecular imaging technology that allows physicians to determine how organs and tissues inside the body are functioning on a molecular and cellular level. PET is a powerful tool for diagnosing and determining the stages of many types of cancer, as well as other ailments such as brain disorders and heart problems.
HMC’s state-of-the-art PET-CT Center for Diagnosis and Research is one of the most technologically advanced in the region, offering complete patient care ranging from diagnosis to assessment of treatment response for cancer, cardiology and neurology patients.
“We hope that this symposium will benefit the daily practice not only of radiologists and nuclear medicine physicians but also other healthcare professionals from different specialties. We have prepared an exciting scientific program and expect that there will be interesting panel discussions,” said Dr Al Tamimi.